Ionis Pharmaceuticals | IONS - Mitarbeiter Gesamtzahl

Aktienkurs
74.18
Täglich Wechseln
2.40 3.34%
Monatlich
2.29%
Jährlich
141.55%
Q2 Prognose
71.70




Mitarbeiter Veränderung Datum
Agios Pharmaceuticals 486 103 2024-12
Alnylam Pharmaceuticals 2.23K 130 2024-12
Arrowhead Research 711 102 2025-12
Astellas Pharma 13.64K 1.11K 2025-12
BioCryst Pharmaceuticals 536 5 2023-12
BioMarin Pharmaceutical 3.04K 361 2024-12
Celltrion 1.07K 94 2015-12
Cspc Pharmaceutical CNY 23.5K 1.34K 2023-12
Divis Laboratories Ltd 17.5K 550 2024-03
Esperion Therapeutics 240 41 2023-12
Exelixis 1.15K 163 2025-12
Halozyme Therapeutics 350 23 2024-12
Ionis Pharmaceuticals 1.07K 142 2024-12
Kangmei Pharma 6.37K 39 2022-12
Knight Therapeutics 698 38 2022-12
Laboratorios Farma 1.99K 242 2022-12
Malin Corporation 5 1 2022-12
Moderna 5.8K 200 2024-12
Nektar Therapeutics 137 79 2023-12
Neurocrine Biosciences 1.8K 400 2024-12
Novartis USD 101.7K 2.62K 2022-12
Omeros 196 17 2022-12
OPKO Health USD 3K 933 2024-12
Organigram Holdings 1.14K 241 2025-12
Pfizer 81K 7K 2024-12
PTC Therapeutics 939 49 2024-12
Qiagen NV USD 6.18K 150 2022-12
Regeneron Pharmaceuticals 13.45K 1.6K 2023-12
Roche Holding 103.61K 2.69K 2022-12
Sarepta Therapeutics 1.37K 58 2024-12
Sartorius 15.94K 2.11K 2022-12
Sino Biopharmaceutical CNY 25.81K 466 2023-12
Tilray USD 2.84K 192 2025-12
Ultragenyx Pharmaceutical 1.29K 18 2024-12
Vertex Pharmaceuticals 6.1K 700 2024-12
Zz Pientze Pharmaceu 2.72K 129 2022-12